January 26, 2023 | less than a minute read

FDA Determined it Will Not Regulate CBD in Food or Dietary Supplements

Get in touch

David DiGiacomo

Partner, Co-Leader, Cannabis

Get in touch

David DiGiacomo

Partner, Co-Leader, Cannabis

Despite an immediate need for more regulatory guidance and consumer safety provisions, the FDA has decided to punt any regulatory guidance with regard to CBD back to Congress. While the FDA has acknowledged the need for a new pathway to regulate these produces, it announced today that the current regulatory framework does not provide sufficient protections to regulate CBD. While they are working on a solution, this continued delay presents major concerns for manufacturers, consumers, advocates and stakeholders.

Today we are announcing that after careful review, the FDA has concluded that a new regulatory pathway for CBD is needed that balances individuals’ desire for access to CBD products with the regulatory oversight needed to manage risks.

www.fda.gov/...